These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8064799)

  • 1. Cyclic peptides with a phosphinic bond as potent inhibitors of a zinc bacterial collagenase.
    Yiotakis A; Lecoq A; Vassiliou S; Raynal I; Cuniasse P; Dive V
    J Med Chem; 1994 Aug; 37(17):2713-20. PubMed ID: 8064799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphinic peptide analogues as potent inhibitors of Corynebacterium rathayii bacterial collagenase.
    Yiotakis A; Lecoq A; Nicolaou A; Labadie J; Dive V
    Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):323-7. PubMed ID: 7945258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of highly potent and selective phosphinic peptide inhibitors of zinc endopeptidase 24-15 using combinatorial chemistry.
    Jirácek J; Yiotakis A; Vincent B; Lecoq A; Nicolaou A; Checler F; Dive V
    J Biol Chem; 1995 Sep; 270(37):21701-6. PubMed ID: 7665587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphinic peptides, the first potent inhibitors of astacin, behave as extremely slow-binding inhibitors.
    Yiallouros I; Vassiliou S; Yiotakis A; Zwilling R; Stöcker W; Dive V
    Biochem J; 1998 Apr; 331 ( Pt 2)(Pt 2):375-9. PubMed ID: 9531473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformations of psi [CH2NH] pseudopeptides. Cyclo[Gly-Pro psi [CH2NH]Gly-D-Phe-Pro]-TFA and cyclo[Gly-Pro psi [CH2NH]Gly-D-Phe-Pro].
    Ma S; Spatola AF
    Int J Pept Protein Res; 1993 Feb; 41(2):204-6. PubMed ID: 8458694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformations of cyclic octapeptides. 4. Diastereomers of cyclo(Gly-Pro-Phe-Ala-Asn-Ala-Val-Ser).
    Vishwanath CK; Go A; Parameswaran KN; Wang YS; Kopple KD
    Int J Pept Protein Res; 1986 Oct; 28(4):428-36. PubMed ID: 3793373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
    Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
    Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional structure of cyclohexapeptides containing a phosphinic bond in aqueous solution: a template for zinc metalloprotease inhibitors. A NMR and restrained molecular dynamics study.
    Cuniasse P; Raynal I; Lecoq A; Yiotakis A; Dive V
    J Med Chem; 1995 Feb; 38(3):553-64. PubMed ID: 7853348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Backbone modifications in cyclic peptides. Conformational analysis of a cyclic pseudopentapeptide containing a thiomethylene ether amide bond replacement.
    Anwer MK; Sherman DB; Spatola AF
    Int J Pept Protein Res; 1990 Oct; 36(4):392-9. PubMed ID: 2079394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide inhibitors of E. collagenolyticum bacterial collagenase--effect of N-methylation. Consequences on biological activity and conformational properties.
    Dive V; Yiotakis A; Roumestand C; Gilquin B; Labadie J; Toma F
    Int J Pept Protein Res; 1992 Jun; 39(6):506-15. PubMed ID: 1399271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and contractile activities of cyclic thrombin receptor-derived peptide analogues with a Phe-Leu-Leu-Arg motif: importance of the Phe/Arg relative conformation and the primary amino group for activity.
    Matsoukas JM; Panagiotopoulos D; Keramida M; Mavromoustakos T; Yamdagni R; Wu Q; Moore GJ; Saifeddine M; Hollenberg MD
    J Med Chem; 1996 Aug; 39(18):3585-91. PubMed ID: 8784457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic beta-casomorphin analogues with mixed mu agonist/delta antagonist properties: synthesis, pharmacological characterization, and conformational aspects.
    Schmidt R; Vogel D; Mrestani-Klaus C; Brandt W; Neubert K; Chung NN; Lemieux C; Schiller PW
    J Med Chem; 1994 Apr; 37(8):1136-44. PubMed ID: 8164255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressive activity of some peptides related to cycloamanide A (CyA A) and to the active fragment of a peptide immunomodulator from ovine colostrum.
    Bolewska-Pedyczak E; Wieczorek Z; Zimecki M; Siemion IZ
    Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):297-301. PubMed ID: 8010869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution conformations of two flexible cyclic pentapeptides: cyclo(Gly-Pro-D-Phe-Gly-Ala) and cyclo(Gly-Pro-D-Phe-Gly-Val).
    Stroup AN; Rockwell AL; Gierasch LM
    Biopolymers; 1992 Dec; 32(12):1713-25. PubMed ID: 1472654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and metal binding of novel Pseudo- oligopeptides containing two phosphinic acid groups.
    Ye Y; Liu M; Kao JL; Marshall GR
    Biopolymers; 2008 Jan; 89(1):72-85. PubMed ID: 17910046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and backbone conformations of cyclic hexapeptides cyclo-(Xxx-Pro-D-Gln)2.
    Kopple KD; Parameswaran KN
    Int J Pept Protein Res; 1983 Mar; 21(3):269-80. PubMed ID: 6853028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of the first potent and selective inhibitor of the zinc endopeptidase neurolysin using a systematic approach based on combinatorial chemistry of phosphinic peptides.
    Jirácek J; Yiotakis A; Vincent B; Checler F; Dive V
    J Biol Chem; 1996 Aug; 271(32):19606-11. PubMed ID: 8702656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrazole analogues of cyclolinopeptide A: synthesis, conformation, and biology.
    Kaczmarek K; Jankowski S; Siemion IZ; Wieczorek Z; Benedetti E; Di Lello P; Isernia C; Saviano M; Zabrocki J
    Biopolymers; 2002 May; 63(6):343-57. PubMed ID: 11920436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined use of molecular dynamics simulations and NMR to explore peptide bond isomerization and multiple intramolecular hydrogen-bonding possibilities in a cyclic pentapeptide, cyclo(Gly-Pro-D-Phe-Gly-Val).
    Liu ZP; Gierasch LM
    Biopolymers; 1992 Dec; 32(12):1727-39. PubMed ID: 1472655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of lipophilicity on the biological activity of cyclic pseudopeptide NK-2 receptor antagonists.
    Quartara L; Fabbri G; Ricci R; Patacchini R; Pestellini V; Maggi CA; Pavone V; Giachetti A; Arcamone F
    J Med Chem; 1994 Oct; 37(21):3630-8. PubMed ID: 7932590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.